784 related articles for article (PubMed ID: 14499769)
1. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
3. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.
Fass R; Inadomi J; Han C; Mody R; O'Neil J; Perez MC
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):247-53. PubMed ID: 22155561
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
Tack J; Koek G; Demedts I; Sifrim D; Janssens J
Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
[TBL] [Abstract][Full Text] [Related]
6. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
7. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
9. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
Milkes D; Gerson LB; Triadafilopoulos G
Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
[TBL] [Abstract][Full Text] [Related]
11. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
Noar MD; Lotfi-Emran S
Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients.
Abu Farsakh N
J Gastroenterol; 2003; 38(11):1042-8. PubMed ID: 14673720
[TBL] [Abstract][Full Text] [Related]
13. Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.
Johnson DA; Katz PO
Rev Gastroenterol Disord; 2008; 8(2):98-108. PubMed ID: 18641592
[TBL] [Abstract][Full Text] [Related]
14. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
Howden CW; Henning JM; Huang B; Lukasik N; Freston JW
Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
[TBL] [Abstract][Full Text] [Related]
15. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
16. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
Nojkov B; Rubenstein JH; Adlis SA; Shaw MJ; Saad R; Rai J; Weinman B; Chey WD
Aliment Pharmacol Ther; 2008 Mar; 27(6):473-82. PubMed ID: 18194508
[TBL] [Abstract][Full Text] [Related]
17. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
18. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
19. What do heartburn sufferers expect from proton pump inhibitors when prescribed for the first time?
Kamolz T; Pointner R
Minerva Gastroenterol Dietol; 2004 Jun; 50(2):143-7. PubMed ID: 15722984
[TBL] [Abstract][Full Text] [Related]
20. [Anti-reflux surgery in patients with adequate response to proton pump inhibitors - is there an indication?].
Horstmann R; Gregor N; Classen C; Röttgermann S; Palmes D
Z Gastroenterol; 2006 Dec; 44(12):1217-22. PubMed ID: 17163371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
